Company / PP&E (Net)
Centessa Pharmaceuticals plc PP&E (Net) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$807.0K
FY2025
5-year range
$162.0K / $1.2M
FY2021-FY2025
Trend
+8.5%
vs FY2024
Sector context
#162 of 195
Health Care
What the data says
Centessa Pharmaceuticals plc's pp&e (net) of $807,000 is lower than 83% of companies in the Health Care sector (FY2025). PP&E (Net) returned to growth in FY2025 after 2 years of decline, reaching $807,000.
Based on SEC 10-K filings.
$807,000 in FY2025 with a 3-year CAGR of -11.6%.
Declined from $1M to $807,000 over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -11.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 17% in Health CareTop 83% of 195This company $807.0K Sector average $771.3M
▼
-99.9% below sector average
Key checks
Key Insights
- 3-year CAGR of -11.6%, indicating a declining trend.
- In FY2025, pp&e (net) increased 8.5% year-over-year.
- Ranks #162 out of 195 companies in the Health Care sector.
- Peak pp&e (net) was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.80 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $807.0K | +8.5% |
| FY2024 | $744.0K | -28.4% |
| FY2023 | $1.0M | -11.0% |
| FY2022 | $1.2M | +621.0% |
| FY2021 | $162.0K | - |
| FY2020 | $0 | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026